Nippon India Pharma Fund-idcw

  • 3 Months
  • 6 Months
  • 1 Year
  • 3 Years
  • 5 Years
  • RSI
3 Months Returns : -0.48%
NAV: ₹119.43 as on Mon Nov 10, 2025
Fund NAV

Fund Overview of Nippon India Pharma Fund-idcw

  • ₹8,736.6 Cr
    AUM
  • ₹119.43
    NAV
  • 1.80%
    Expense Ratio
  • Equity
    Fund Category
As on Mon Nov 10, 2025

Returns of Nippon India Pharma Fund-idcw

Tenure Absolute(%) Annualised(%) Category Average(%)
3 Months -0.48% NA 6.12%
6 Months 11.00% NA 12.92%
1 Year -1.91% -1.91% 6.04%
2 Years 47.27% 21.35% 24.93%
3 Years 80.00% 21.64% 25.71%
5 Years 118.06% 16.87% 19.91%
7 Years 231.28% 18.66% NA
10 Years 228.44% 12.63% 12.78%
View More
As on Mon Nov 10, 2025

Dividend of Nippon India Pharma Fund-idcw : 100.00%

Dividends are declared by the fund house based on the income generated from the underlying assets. While many mutual funds distribute dividends annually, the payout frequency ultimately depends on the fund house’s decision

Asset Allocation

equities

99.44%

debt instruments

0.00%

other assets or cash equivalents

0.56%
Large Cap: 49.42%
Mid Cap: 20.18%
Small Cap: 30.40%
Other: 0.00%
Top Holdings
Sun Pharmaceutical Industries Ltd
12.22%
Sun Pharmaceutical Industries Ltd
12.29%
Sun Pharmaceutical Industries Ltd
12.29%
Divi's Laboratories Ltd
7.55%
Lupin Ltd
7.26%
 
Top Sectors
Healthcare
298.33%
Unspecified
1.68%
Detailed Portfolio Analysis
As on Mon Nov 10, 2025
Invest Now

About Fund

About Nippon India Pharma Fund-idcw

Nippon India Pharma Fund-idcw is one Equity mutual fund offered by Nippon India Mutual Fund. Launched on 05 Jun 2004, the fund aims Long term capital growth. Investment in equity and equity related Securities of pharma & other associated companies. It manages assets worth ₹8,736.6 crore as on Thu Jul 31, 2025. The expense ratio stands at 1.8%.
The portfolio allocation consists of 99.44% in equities, 0.00% in debt instruments, 0.56% in other assets or cash equivalents. Managed by Sailesh Raj Bhan, it has delivered a return of -1.91% in the last year, a total return since inception of 20.24%.

The latest dividend was declared on 21 Feb 2025 at 100.00% of face value. Read more
  • Sailesh Raj Bhan

    Fund Manager

  • Mr. Bhan is an MBA (Finance) and CFA.

    Manager Education

Key Metrics of Nippon India Pharma Fund-idcw

  • Standard Deviation
    15.03%
  • Sharpe Ratio
    1.01%
  • Alpha
    -0.22%
  • Beta
    0.91%

Fund Details

Fund Names Nippon India Pharma Fund-idcw
Inception Date 05 Jun 2004
Lock In No Lock-in
SIP Minimum Investment amount ₹ 100
SWP Minimum Investment amount ₹ 500
STP Minimum Investment amount ₹ 100
 
Risk Principal at very high risk
Category Average Annual Returns 6.04
More Details
Highest NAV in last 52 weeks & Lowest NAV in last 52 weeks

Top Performing Mutual Funds

Fund Names AUM (Cr) 1M 3M 1Yr 3Yr 5Yr
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth trend ₹6,104 -0.69% 3.29% 4.56% 28.17% 22.19%
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth trend ₹6,104 -0.77% 3.06% 3.67% 27.07% 21.12%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth trend ₹872 -0.12% 2.45% 1.23% 23.22% 18.47%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth trend ₹872 -0.22% 2.10% -0.06% 21.58% 16.80%
increase growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns

More funds from Nippon India Mutual Fund

Fund Names AUM (Cr) 1M 3M 6M 1Yr 3Yr
Nippon India Pharma Fund-growth increase ₹8,737 -0.03% 2.09% 5.85% -0.43% 21.36%
Nippon India Pharma Fund Direct-growth increase ₹8,737 0.05% 2.33% 6.34% 0.48% 22.45%
Nippon India Pharma Fund Direct-idcw increase ₹8,737 0.05% 2.33% 6.34% 0.48% 22.45%
Nippon India Nifty Pharma Etf - Growth increase ₹942 0.73% 4.55% 6.60% -0.22% 20.48%
increase growth is based on 1-month returns of the funds

Mutual Fund Calculator

I want to invest Pro Tip
Financial experts suggest that a person should invest 10-15% of their monthly income for long-term financial growth
/Month
I want to invest for Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 29
  • 31
  • 32
  • 33
  • 34
  • 36
  • 37
  • 38
  • 39
  • 40
Expected return Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 30
Total Investment
Wealth Gained
Total Wealth
Start Investing
I want to save
I want to invest for Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 29
  • 31
  • 32
  • 33
  • 34
  • 36
  • 37
  • 38
  • 39
  • 40
Expected return Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 30
Total Investment
Wealth Gained
Monthly Investment
Invest Now
You can also get Tax Free Maturity/ Returns? You can also get Tax Free Maturity/ Returns?

Top Mutual Funds

Fund Names AUM (Cr) NAV 3Yr 5Yr 10Yr
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth trend ₹6,104 ₹43.36 28.17% 22.19% -
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth trend ₹6,104 ₹40.14 27.07% 21.12% -
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth trend ₹872 ₹31.16 21.58% 16.80% -
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth trend ₹872 ₹34.35 23.22% 18.47% -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.05 22.09% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.05 22.09% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.05 22.09% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.05 22.09% - -
View More
Top funds are based on Fund AUM

Detailed Portfolio

Stocks Sector % of Holding Value
Sun Pharmaceutical Industries LtdHealthcare12.22%₹1,067.77 Cr
Sun Pharmaceutical Industries LtdHealthcare12.29%₹997.45 Cr
Sun Pharmaceutical Industries LtdHealthcare12.29%₹997.45 Cr
Divi's Laboratories LtdHealthcare7.55%₹659.57 Cr
Lupin LtdHealthcare7.26%₹589.44 Cr
Lupin LtdHealthcare7.26%₹589.44 Cr
Divi's Laboratories LtdHealthcare7.01%₹568.97 Cr
Divi's Laboratories LtdHealthcare7.01%₹568.97 Cr
Cipla LtdHealthcare6.48%₹525.41 Cr
Cipla LtdHealthcare6.48%₹525.41 Cr
Lupin LtdHealthcare5.93%₹517.77 Cr
Cipla LtdHealthcare5.69%₹497.47 Cr
Dr. Reddy's Laboratories LtdHealthcare5.69%₹497.46 Cr
Apollo Hospitals Enterprise LtdHealthcare5.57%₹486.47 Cr
Apollo Hospitals Enterprise LtdHealthcare5.92%₹480.69 Cr
Apollo Hospitals Enterprise LtdHealthcare5.92%₹480.69 Cr
Dr. Reddy's Laboratories LtdHealthcare5.91%₹479.21 Cr
Dr. Reddy's Laboratories LtdHealthcare5.91%₹479.21 Cr
Medplus Health Services LtdHealthcare3.86%₹337.54 Cr
Vijaya Diagnostic Centre LtdHealthcare3.55%₹310.33 Cr
Glaxosmithkline Pharmaceuticals LtdHealthcare3.31%₹288.82 Cr
Vijaya Diagnostic Centre LtdHealthcare3.56%₹288.67 Cr
Vijaya Diagnostic Centre LtdHealthcare3.56%₹288.67 Cr
Medplus Health Services LtdHealthcare3.39%₹274.75 Cr
Medplus Health Services LtdHealthcare3.39%₹274.75 Cr
Gland Pharma LtdHealthcare3.12%₹272.67 Cr
Ajanta Pharma LtdHealthcare3.02%₹263.95 Cr
Gland Pharma LtdHealthcare3.24%₹263.00 Cr
Gland Pharma LtdHealthcare3.24%₹263.00 Cr
Glaxosmithkline Pharmaceuticals LtdHealthcare2.99%₹242.89 Cr
Glaxosmithkline Pharmaceuticals LtdHealthcare2.99%₹242.89 Cr
Abbott India LtdHealthcare2.70%₹236.28 Cr
Ajanta Pharma LtdHealthcare2.85%₹230.84 Cr
Ajanta Pharma LtdHealthcare2.85%₹230.84 Cr
Thyrocare Technologies LtdHealthcare2.63%₹229.89 Cr
Sai Life Sciences Ltd.Healthcare2.71%₹219.97 Cr
Sai Life Sciences Ltd.Healthcare2.71%₹219.97 Cr
Dr. Lal Pathlabs LtdHealthcare2.38%₹207.68 Cr
Sai Life Sciences Ltd.Healthcare2.36%₹206.62 Cr
Abbott India LtdHealthcare2.48%₹201.15 Cr
Abbott India LtdHealthcare2.48%₹201.15 Cr
Narayana Hrudayalaya LtdHealthcare2.26%₹197.12 Cr
Mankind Pharma Ltd.Healthcare2.23%₹194.46 Cr
Aurobindo Pharma LtdHealthcare2.22%₹194.07 Cr
Zydus Lifesciences LtdHealthcare2.22%₹194.02 Cr
Dr. Lal Pathlabs LtdHealthcare2.34%₹189.93 Cr
Dr. Lal Pathlabs LtdHealthcare2.34%₹189.93 Cr
Aurobindo Pharma LtdHealthcare2.27%₹184.55 Cr
Aurobindo Pharma LtdHealthcare2.27%₹184.55 Cr
Mankind Pharma Ltd.Healthcare2.27%₹184.50 Cr
Mankind Pharma Ltd.Healthcare2.27%₹184.50 Cr
Thyrocare Technologies LtdHealthcare2.25%₹182.54 Cr
Thyrocare Technologies LtdHealthcare2.25%₹182.54 Cr
Narayana Hrudayalaya LtdHealthcare2.20%₹178.84 Cr
Narayana Hrudayalaya LtdHealthcare2.20%₹178.84 Cr
Jb Chemicals & Pharmaceuticals LtdHealthcare2.02%₹176.87 Cr
Alkem Laboratories LtdHealthcare2.16%₹175.60 Cr
Alkem Laboratories LtdHealthcare2.16%₹175.60 Cr
Jb Chemicals & Pharmaceuticals LtdHealthcare2.11%₹170.91 Cr
Jb Chemicals & Pharmaceuticals LtdHealthcare2.11%₹170.91 Cr
Pfizer LtdHealthcare1.89%₹165.31 Cr
Alkem Laboratories LtdHealthcare1.86%₹162.85 Cr
Biocon LtdHealthcare1.98%₹160.93 Cr
Biocon LtdHealthcare1.98%₹160.93 Cr
Pfizer LtdHealthcare1.98%₹160.27 Cr
Pfizer LtdHealthcare1.98%₹160.27 Cr
Biocon LtdHealthcare1.77%₹154.74 Cr
Sanofi India LtdHealthcare1.54%₹134.13 Cr
Suraksha Diagnostic Ltd.Healthcare1.34%₹117.26 Cr
Suraksha Diagnostic Ltd.Healthcare1.43%₹116.25 Cr
Suraksha Diagnostic Ltd.Healthcare1.43%₹116.25 Cr
Ipca Laboratories LtdHealthcare1.33%₹115.76 Cr
Torrent Pharmaceuticals LtdHealthcare1.30%₹113.52 Cr
Ipca Laboratories LtdHealthcare1.35%₹109.80 Cr
Ipca Laboratories LtdHealthcare1.35%₹109.80 Cr
Torrent Pharmaceuticals LtdHealthcare1.35%₹109.31 Cr
Torrent Pharmaceuticals LtdHealthcare1.35%₹109.31 Cr
Sanofi India LtdHealthcare1.32%₹107.08 Cr
Sanofi India LtdHealthcare1.32%₹107.08 Cr
Fortis Healthcare LtdHealthcare1.32%₹107.06 Cr
Fortis Healthcare LtdHealthcare1.32%₹107.06 Cr
Sanofi Consumer Healthcare India LtdHealthcare1.20%₹104.86 Cr
Sanofi Consumer Healthcare India LtdHealthcare1.24%₹100.86 Cr
Sanofi Consumer Healthcare India LtdHealthcare1.24%₹100.86 Cr
Fortis Healthcare LtdHealthcare1.08%₹94.65 Cr
Syngene International LtdHealthcare1.05%₹91.43 Cr
Anthem Biosciences Ltd.Healthcare0.99%₹80.57 Cr
Anthem Biosciences Ltd.Healthcare0.99%₹80.57 Cr
Anthem Biosciences Ltd.Healthcare0.92%₹80.36 Cr
Syngene International LtdHealthcare0.98%₹79.76 Cr
Syngene International LtdHealthcare0.98%₹79.76 Cr
Akums Drugs And Pharmaceuticals Ltd.Healthcare0.90%₹78.68 Cr
Akums Drugs And Pharmaceuticals Ltd.Healthcare0.82%₹66.89 Cr
Akums Drugs And Pharmaceuticals Ltd.Healthcare0.82%₹66.89 Cr
Emcure Pharmaceuticals Ltd.Healthcare0.76%₹66.29 Cr
Emcure Pharmaceuticals Ltd.Healthcare0.74%₹60.19 Cr
Emcure Pharmaceuticals Ltd.Healthcare0.74%₹60.19 Cr
Indoco Remedies LtdHealthcare0.67%₹58.32 Cr
Astrazeneca Pharma India LtdHealthcare0.66%₹57.48 Cr
Astrazeneca Pharma India LtdHealthcare0.70%₹56.97 Cr
Astrazeneca Pharma India LtdHealthcare0.70%₹56.97 Cr
Indoco Remedies LtdHealthcare0.66%₹53.57 Cr
Indoco Remedies LtdHealthcare0.66%₹53.57 Cr
RepoUnspecified0.46%₹37.52 Cr
RepoUnspecified0.46%₹37.52 Cr
Orchid Pharma LtdHealthcare0.42%₹36.48 Cr
Orchid Pharma LtdHealthcare0.43%₹34.59 Cr
Orchid Pharma LtdHealthcare0.43%₹34.59 Cr
Net Current AssetsUnspecified0.29%₹24.91 Cr
RepoUnspecified0.26%₹22.82 Cr
Concord Biotech Ltd.Healthcare0.23%₹19.75 Cr
Zydus Lifesciences LtdHealthcare0.23%₹19.05 Cr
Zydus Lifesciences LtdHealthcare0.23%₹19.05 Cr
Concord Biotech Ltd.Healthcare0.23%₹18.41 Cr
Concord Biotech Ltd.Healthcare0.23%₹18.41 Cr
Net Current AssetsUnspecified0.10%₹5.00 Cr
Net Current AssetsUnspecified0.10%₹5.00 Cr
Others Mrgn MoneyUnspecified0.00%₹0.21 Cr
Others Mrgn MoneyUnspecified0.00%₹0.21 Cr
Others Mrgn MoneyUnspecified0.00%₹0.16 Cr
View More

Top Equity Funds

Fund Names NAV 3Yr 5Yr 52 weeks high
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth increase ₹43.36 28.17% 22.19% 44.69
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth increase ₹40.14 27.07% 21.12% 41.47
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth increase ₹34.35 23.22% 18.47% -
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth increase ₹31.16 21.58% 16.80% -
increase growth is based on 5Y returns of the funds

Frequently Asked Questions

Nippon India Pharma Fund-idcw

What is the current AUM of Nippon India Pharma Fund-idcw?

As of Thu Jul 31, 2025, Nippon India Pharma Fund-idcw manages assets worth ₹8,736.6 crore

How has Nippon India Pharma Fund-idcw performed recently?

  • 3 Months: -0.48%
  • 6 Months: 11.00%

What is the long-term performance of Nippon India Pharma Fund-idcw?

  • 3 Years CAGR: 21.64%
  • 5 Years CAGR: 16.87%
  • Since Inception: 20.24%

What is the portfolio composition of Nippon India Pharma Fund-idcw?

Equity: 99.44%, Debt: 0.00%, Others: 0.56%.

Who manages Nippon India Pharma Fund-idcw?

Nippon India Pharma Fund-idcw is managed by Sailesh Raj Bhan from Nippon India Mutual Fund.

When was the last dividend declared by Nippon India Pharma Fund-idcw?

Latest dividend was declared on 21 Feb 2025 at 100.00% of face value.

What is the market-cap allocation of Nippon India Pharma Fund-idcw?

Large Cap: 49.42%, Mid Cap: 20.18%, Small Cap: 30.40%.

Which are the top companies Nippon India Pharma Fund-idcw has invested in?

  • Sun Pharmaceutical Industries Ltd – 12.22% of the fund's portfolio
  • Sun Pharmaceutical Industries Ltd – 12.29% of the fund's portfolio
  • Sun Pharmaceutical Industries Ltd – 12.29% of the fund's portfolio
  • Divi's Laboratories Ltd – 7.55% of the fund's portfolio
  • Lupin Ltd – 7.26% of the fund's portfolio

Which are the major sectors Nippon India Pharma Fund-idcw focuses on?

  • Healthcare – 298.33% of the fund's portfolio
  • Unspecified – 1.68% of the fund's portfolio
View more FAQ's

Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.

Please consult your financial advisor for an informed decision.

Past performance may not be indicative of future results.

The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.

Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.

Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.

For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.

For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.

Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved

^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.

Explore the popular searches and stay informed

Close
Download the Policybazaar app
to manage all your insurance needs.
INSTALL
Claude
top

Become a Crorepati

Invest ₹10K/Month & Get ₹1 Crore# Returns

Mobile +91
*T&C Applied.